Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Sex-related factors in multiple sclerosis susceptibility and progression.
Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Potassium-Retaining Diuretics: Amiloride
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.
Poor sleep in patients with multiple sclerosis.
Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis.
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
Dopaminergic Modulation of CD4+CD25 Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy.
No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.
Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability.
Increased axonal expression of nectin-1 in multiple sclerosis plaques.
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
Early relapses, onset of progression, and late outcome in multiple sclerosis.
Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro.
Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on alemtuzumab.
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Therapeutic Testosterone Administration Preserves Excitatory Synaptic Transmission in the Hippocampus during Autoimmune Demyelinating Disease.
lipid-specific IgM bands in csf associated with a reduced risk of developing pml during treatment with natalizumab.
First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks.
Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.
An Open Label Extension of the LAQ/5062 and LAQ/5063 Studies to Assess the Long Term Safety and Tolerability of Laquinimod 0.6mg in RRMS Patients

Pages